Brussels, Belgium (PRWEB UK) 19 September 2014
The partners of ENTENTE-project with the European Commission and EuropaBio (the European relationship for BioIndustries) are proud to announce the companies chosen to provide on ENTENTE Life Sciences Investment Forum, taking place on October 9th during the Stanhope Hotel in Brussels, during the 2014 European Biotech Week.
The 28 European chosen organizations have-been assessed because of the choice committee members among a pool of 100 innovative businesses mixed up in lifestyle Sciences sector and pursuing investment opportunities and intercontinental visibility. The entrepreneurs will pitch their particular innovation, advancements and needs before a worldwide jury consisting of about 40 company angels, venture capitalists, corporate people alongside industry experts.
Range of selected organizations:
A2M Pharma GmbH [DE] – A2M Pharma is a neurology medication development spin-off from Schwarz Pharma.
BC systems [FI] – BC Platforms is a respected pioneer inside quickly developing genomic information administration areas.
BCO Pharma Ltd. [IE] – The product is a combined drug and medicine delivery unit to deal with otitis news.
BioTech Tools [BE] – BioTech Tools. is a medical phase bio-pharmaceutical business dedicated to the development and commercialization of novel immunotherapy medications for respiratory and meals allergies based on the ASIT+ technology system.
BIOXODES SA [BE] – Bioxodes is a start up building an all natural product handling blockbuster aerobic and potentially orphan areas.
CALCISCO AG [CH] – CALCISCO provides novel blood test when it comes to evaluation of calcification propensity and enhanced aerobic threat management.
CluePoints [BE] – CluePoints is a Central Statistical tracking option that employs unique statistical formulas to determine the quality, accuracy and integrity of clinical trial information.
Coimbra Genomics [PT] – Coimbra Genomics (CG) develops computer software tools for precision medicine.
CuraVac [BE] – CuraVac offers healing Vaccines for Autoimmune Diseases.
DBS program [CH] – DBS System is a bloodstream collection change, enabling blood sampling everywhere, anytime and also by anyone.
DermoSafe SA [CH] – DermoSafe SA provides an entire tele-medicine Solution & Services for melanoma early recognition.
DualTPharma [NL] – DualTPharma develops highly-potent and proprietary pharmaceuticals for customized cancer therapy.
ENTEROME [FR] – Enterome is pioneering the introduction of book products to guide personalized diagnostics & treatments and the medical improvement new medications in microbiome-related conditions.
EyeTechCare [FR] – EyeTechCare’s proprietary ultrasound technology provides non-invasive remedy for glaucoma.
Inflamalps SA [CH] – Inflamalps develops novel therapies for the treatment of autoimmune conditions of the eye.
LindaCare [BE] – LindaCare is a Remote Patient Telemonitoring Unified Dashboard & efficiency Tool.
Real time great [HR] – BodyRecog is a forward thinking ICT system for body proportions recognition and analysis.
Magnomics [PT] – Magnomics offers a simple to operate Point-of-Care in vitro diagnostic product for microbial recognition.
Nano Live [CH] – Nanolive has developed a disruptive proprietary technology, which allows the first-time to explore a living cell in 3D without harming it.
OMEICOS Therapeutics [DE] – Omeicos provides novel eicosanoid-like medications the therapy and prevention of atrial fibrillation.
OncoLab Diagnostics GmbH [AT] – OncoLab Diagnosticss centers on manufacturing and commercialisation of proprietary revolutionary technologies to diagnose disease previously, and also to identify and analyse traces of cancer tumors in the patient’s human anatomy.
PETsys Electronics – healthcare PET Detectors, SA [PT] – Electronics and Detectors for PET scanners to early disease’s detection.
Plux [PT] – Plux produces powerful quantified self services and products for Physiotherapists and Researchers utilizing a cutting-edge biosignal monitoring platform.
Pragma Therapeutics [FR] – Pragma Therapeutics is a biopharmaceutical business in creation, establishing revolutionary small molecules for the treatment of severe tension disorders.
Quanta Fluid Systems [GB] – A pioneering UK-based health products business centering on the development and commercialization of a novel cartridge-based haemodialysis system.
SamanTree Technologies [CH] – Digital microscopy company, aided by the sight to allow intra-operative point-of-care electronic pathology for cyst surgery assistance.
TENSIVE [IT] – Tensive is a rising biomedical startup that develops vascularizable biodegradable prostheses aiming to offer normal breast reconstruction/augmentation.
SMART s.r.l. [IT] – the newest generation of prospects for neuromodulation (NM) for remedy for chronic pain and Parkinson: unbreakable, less unpleasant and cheaper.
The ENTENTE lifetime Sciences Investment Forum will likely be especially focused on strengthening the life sciences innovation potential in European countries through advertising and empowering innovative SMEs searching for monetary facilitation and international exposure.
Each day members will have the chance to help inspiring panel conversations from crucial players associated with the business and also to revolutionary organizations’ presentations, but a lot of networking opportunities including targeted one2one group meetings.
The orifice panel, moderated by Claus A. Andersson (Sunstone Capital) will concentrate on ‘crucial investment trends in biotech and medtech and find out the efforts of Ruxandra Draghia-Akli (European Commission, Directorate Health Research) Mark Wilson (GlaxoSmithKline) Francesco De Rubertis (list Ventures) Florent Gros (Novartis Venture Funds.
Discover more information right here.
For further information in the ENTENTE lifestyle Sciences Investment Forum be sure to contact Annalisa Gardella from European countries Unlimited via post at annalisa(at)e-unlimited(dot)com or via phone at +32 (0) 2 643 36 91.
ENTENTE (FP7 task) may be the first European community to enhance knowledge transfer activity in wellness study among educational and public organisations and commercial equivalent. The task encourages transnational collaboration among all stakeholders through networking activities, revealing knowledge and best methods and applying an exchange programme for experts of tech Transfer in Health.
See much more at: /entente-health.eu/
EuropaBio may be the European Association for Bioindustries, joining together bioscience businesses from all fields of study and development, testing, manufacturing and distribution of biotechnology items. Its business, associate and nationwide organization users take part in analysis, development, screening, production and commercialization of biotechnology products and processes, and also many tasks: individual and animal healthcare, diagnostics, bio-informatics, chemical compounds, crop defense, agriculture, meals and environmental products. See more at: http://www.europabio.org